Monitoring of patients given second-generation antipsychotic agents

被引：4
|
作者：
Olson, Kari L. [1 ]
Delate, Thomas
Duagn, Daniel J.
机构：
[1] Kaiser Permanente, Dept Pharm, Aurora, CO USA
[2] Univ Colorado, Hlth Sci Ctr, Sch Pharm, Denver, CO 80202 USA
来源：
PSYCHIATRIC SERVICES | 2006年 / 57卷 / 07期
关键词：
D O I：
10.1176/appi.ps.57.7.1045-a
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：1045 / 1046
页数：2
相关论文
共 50 条
  • [21] Second-generation antipsychotic medication combinations for schizophrenia
    Eisen, Carol
    Shaner, Roderick
    Unutzer, Jurgen
    Fink, Arlene
    Wells, Kenneth B.
    PSYCHIATRIC SERVICES, 2008, 59 (03) : 235 - 235
  • [22] Second-generation antipsychotic medications in children and adolescents
    Cheng-Shannon, J
    McGough, JJ
    Pataki, C
    McCracken, JT
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2004, 14 (03) : 372 - 394
  • [23] Iloperidone (Fanapt) - Another Second-Generation Antipsychotic
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2010, 52 (1332): : 13 - 14
  • [24] Asenapine: A Clinical Review of a Second-Generation Antipsychotic
    Stoner, Steven C.
    Pace, Heather A.
    CLINICAL THERAPEUTICS, 2012, 34 (05) : 1023 - 1040
  • [25] Second-Generation Antipsychotic Drugs for Children and Adolescents
    Onishi, Yuichi
    Mikami, Katsunaka
    Kimoto, Keitaro
    Watanabe, Natsuru
    Takahashi, Yuki
    Akama, Fumiaki
    Yamamoto, Kenji
    Matsumoto, Hideo
    JOURNAL OF NIPPON MEDICAL SCHOOL, 2021, 88 (01) : 10 - 16
  • [26] Dosing equivalency of second-generation antipsychotic medications
    Buckley, PF
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (05) : 501 - 502
  • [27] Metabolic Syndrome Identification in Patients Treated With Second-Generation Antipsychotic Medications
    Trigueiro, Anthony J. P.
    Ramirez, Jeffery
    Hennessey, Erin
    Beqiri, Mirjeta
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2022, 60 (08) : 11 - 18
  • [28] Cognitive effects of second-generation antipsychotic polypharmacy in stabilized patients with schizophrenia
    Park, D. Y.
    Song, H.
    Choi, J.
    Kang, S. H.
    Lee, J. I.
    Lee, W. H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S403 - S404
  • [29] Food intake and reward mechanisms in patients with schizophrenia: Implications for metabolic disturbances and treatment with second-generation antipsychotic agents
    Elman, Igor
    Borsook, David
    Lukas, Scott E.
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 (10) : 2091 - 2120
  • [30] Food Intake and Reward Mechanisms in Patients with Schizophrenia: Implications for Metabolic Disturbances and Treatment with Second-Generation Antipsychotic Agents
    Igor Elman
    David Borsook
    Scott E Lukas
    Neuropsychopharmacology, 2006, 31 : 2091 - 2120
12345